Le Lézard
Classified in: Science and technology
Subject: PLW

Nomadix Earns Patent for Enhancing Passpoint (Hotspot 2.0) with Loyalty Program Integrations


Enabling Digital Engagement and Tiered, Location-Based Services for Visitor-Based Networks

LOS ANGELES, Feb. 6, 2024 /PRNewswire-PRWeb/ -- Nomadix® Inc., bringing connected experiences to life, was issued U.S. Patent No. 11,855,986 by the United States Patent and Trademark Office (USPTO) on December 26, 2023. The patent, titled "Management of network intercept portals for network devices with durable and non-durable identifiers," represents Nomadix's ongoing innovations in networking technology and adds to its growing patent portfolio.

"Nomadix has a long history of innovation including the invention of the visitor-based network and creation of the first captive portal," said Ted Helvey, chairman and CEO at Nomadix.

The patent relates to using captive portals to securely manage network access requests under Passpoint, formerly known as Hotspot 2.0. Nomadix's technology gives hotels and other organizations greater control and visibility over their visitor-based networks, helping drive digital engagement and deliver customized, location-based services and tiered upgrade options. For example, venues leveraging visitor-based networks can offer Passpoint through loyalty apps to offer secure connections to the network, while also enabling better engagement, upselling, tiered service offerings (i.e., events, Wi-Fi upgrades), and payment acceptance throughout the guest's stay at the property.

"Nomadix has a long history of innovation including the invention of the visitor-based network and creation of the first captive portal," said Ted Helvey, chairman and CEO at Nomadix. "This latest patent is of similar importance in the next generation of secure authentication and shows our team's continued commitment to creating technology that provides personalized connectivity and digital engagement opportunities for our customers in hospitality, multi-tenant, retail and beyond."

The patent, part of Nomadix's growing network management portfolio, is based on an application filed in February 2020 by inventor Vadim Olshansky. For more information, visit the USPTO website.

About Nomadix
Nomadix brings connected experiences to life. For over 25 years, Nomadix has been a trusted vendor to the world's largest brands, delivering powerful and personalized connectivity and digital engagement solutions designed with real people in mind. Providing the backbone of visitor-based networks and managed Wi-Fi to properties and venues of any size in over 150 countries, Nomadix enables companies to connect, manage and engage in ways that redefine their digital customer experiences, help them make better business decisions and increase customer lifetime value. For more information, visit nomadix.com.

Media Contact

Aubrey Coggins, Nomadix, 818-575-2565, [email protected]https://nomadix.com/

SOURCE Nomadix


These press releases may also interest you

at 16:15
CareDx, Inc. ? The Transplant Companytm ? a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers ? today...

at 16:10
KLDiscovery Inc. ("KLD"), a leading global provider of electronic discovery, information governance and data recovery technology solutions will announce first quarter 2024 financial results following the market close on Wednesday, May 8, 2024....

at 16:10
Quantum Corporation ("Quantum" or the "Company"), a leader in solutions for AI and unstructured data, today provided an update related to the Company's efforts to become current with its SEC financial reports. As previously announced on April 12,...

at 16:09
The Board of Directors of Dover Corporation today declared a regular quarterly cash dividend of $0.51 (fifty-one cents) per share, payable on June 14, 2024, to shareholders of record as of May 31, 2024....

at 16:05
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of...

at 16:05
Omnicell, Inc. , a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT. Live and archived webcasts of the presentation...



News published on and distributed by: